However, the detection rate of breast cancer for CBE is only 47% when the tumors are less than 1 centimeter while mammography has given us a 70% detection rate. By the time a tumor is detected by palpation or found mammographically, it has already been growing and developing for 8-10 years.
Mammography has a high false positive rate. Only 1:6 biopsies are found to be positive for cancer when performed due to a positive mammogram or CBE. This places additional stressors on women who undergo these procedures.
Other risks of mammography include the radiation that each breast is exposed to during a mammogram. During a chest X-ray, a person receives 1/1000 of a rad, or radiation absorbed dose. This type of X-ray is a high energy X-ray. During a mammogram, however, the X-ray used is a low energy X-ray and results in 1 rad or a 1000-fold greater exposure than a simple chest X-ray.
It has been suggested that the low energy X-ray used may cause greater biological damage which is cumulative over time. In a journal entitled Radiation Research and published in 2004, the author concludes that the risks associated with mammography screening may be five times higher than previously assumed and the risk-benefit relationship of mammography exposures need to be re-examined.
In 1982, the FDA approved thermography as an adjunctive tool for breast cancer screening. Digital Infrared Thermal Imaging, also known as DITI measures heat emitted from the body and is accurate to 1/100th of a degree. Certified Clinical Thermographers follow strict guidelines and transmit their scans for interpretation by board certified thermologists. DITI examines physiology, not structure.
It is in this capacity that DITI can monitor breast HEALTH over time and alert a patient or physician to a developing problem; possibly before a lump can be seen on X-ray or palpated clinically. There are no test limitations such as breast density. Women with cosmetic implants are great candidates for thermography which emits no radiation and no compression. Contact is never made during a thermographic scan.
Clinical research studies continue to support thermography's role as an adjunctive tool in breast cancer screening and the only tool that measures breast health. There are now more than 800 publications on over 300,000 women in clinical trials.
A recent finding published in the American Journal of Radiology in 2003 showed that thermography has 99% sensitivity in identifying breast cancer with single examinations and limited views. Scientists concluded that a negative thermogram is powerful evidence that cancer is not present.
In conclusion, women need to begin breast health screening early; as young as age 25. This can provide women with the earliest possible indication that further investigation is necessary. It takes approximately 15 years for a breast cancer to form and lead to death.
If "early detection is the best prevention," let's start using technology that truly allows for the earliest possible alert to a developing problem.
However, the detection grade of breast canker for CBE is only 47% when the tumors are less than 1 centimeter while mammography has given us a 70% detection cost. By the time palpation detected a swelling or found mammographically, it has already been rising and developing for 8-10 living.
Mammography has a high incorrect confirmed assess. Only 1:6 biopsies are found to be activist for growth when performed due to a confident mammogram or CBE. The chairs additional stressors on women who undergo these procedures.
Other risks of mammography include the radiation that each breast is exposed to during a mammogram. During a chest X-ray, the qualities receives 1/1000 of a rad, or radiation absorbed dose. This style of X-ray is a high energy X-ray. During a mammogram, however, the X-ray used is a low energy X-ray and results in 1 rad or a 1000-fold bigger exposure than an austere chest X-ray.
It has been optional that the low energy X-ray used may instigate greater biological hurt which is cumulative over time. In a journal free Radiation Research and available in 2004, the origin determines that the risks associated with mammography analysis may be five period elevated than previously implicit and the threat-profit relationship of mammography exposures penury to be re-examined.
In 1982, the FDA agreed thermography as an adjunctive tool for breast bane test. Digital Infrared Thermal Imaging, also known as DITI actions ardor emitted from the body and is accurate to 1/100th of a gradation. Certifying Clinical Thermographers hunt strict guidelines and transmit their scans for interpretation by panel trained thermologists. DITI examines physiology, not formation.
It is in this office that DITI can overseer breast HEALTH over time and alert a patient or surgeon to a developing hitch; maybe before a lump can be seen on X-ray or palpated clinically. There are no test limitations such as breast density. Women with surface implants are great candidates for thermography which emits no radiation and no compression. Contact is never made during a thermographic check.
Clinical seek studies remain to defense thermography's function as an adjunctive tool in breast scourge program and the only tool that measures breast fitness. There are now more than 800 publications on over 300,000 women in clinical trials.
A recent finding published in the American Journal of Radiology in 2003 showed that thermography has 99% sensitivity in identifying breast tumor with track examinations and imperfect views. Scientists determined that an unhelpful thermogram is sturdy facts that menace is not there.
In conclusion, women penury to start breast wellbeing show early; as fresh as age 25. This could supply women with the original probable indication that advance investigation is essential. It takes about 15 being for a breast menace to form and prime to murder.
If "early detection is the best prevention," let's start with technology that honestly allows for the initial possible alert to a developing problem.
Both Adrien Brody & Jody Siena are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.
Adrien Brody has sinced written about articles on various topics from Health, Cosmetic Surgery and Breast Enlargements. Adrien Brody is a business writer specializing in health and beauty products and has written authoritative articles on the industry. To learn more about breast enhancement, make sure you visit. Adrien Brody's top article generates over 165000 views. to your Favourites.
Jody Siena has sinced written about articles on various topics from Breastfeeding, Supplements and Nutrition. Visit the website to learn about. Jody Siena's top article generates over 49500 views. to your Favourites.